Literature DB >> 17573603

Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India.

N Joglekar1, S Joshi, M Kakde, G Fang, M Cianciola, S Reynolds, S Mehendale.   

Abstract

Acceptability of PRO2000 Gel, a candidate vaginal microbicide, among participants of its Phase I safety study in Pune, India is reported here. Forty-two eligible women were enrolled in a study requiring twice daily intra-vaginal product use for 14 consecutive days between menses. Acceptability was assessed at study exit through structured questionnaires among 41 participants who completed the product use, and five focus group discussions involving 31 study participants. The participants generally liked the product (40/41, 97.2%), especially its colour (40, 97.2%) and consistency (35, 85.3%). Thirty-four participants reported sexual intercourse within one hour of product use, at least once during the study period and sexual pleasure was reported to be better or unaffected among (30, 88.2%) participants. Nearly 70% did not like its smell and mentioned preference for a product that would be unnoticeable to the male partner. Participating women were concerned about privacy in usage and storage of the product. Acceptability of PRO2000 vaginal gel was good, but its smell will have to be improved. Counselling to address women's concerns about privacy and storage will be crucial. Women's preference for unnoticeable product indicates their empowerment and willingness to accept female-controlled options for HIV prevention.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17573603     DOI: 10.1080/09540120601133576

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  13 in total

1.  Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Julia G Shaw; E Milu Kojic; Patrick F Kiser; David R Friend; David F Katz
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-09       Impact factor: 2.205

2.  Innovative sensory methods to access acceptability of mixed polymer semisoft ovules for microbicide applications.

Authors:  Toral Zaveri; Cordelia A Running; Lahari Surapaneni; Gregory R Ziegler; John E Hayes
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

3.  Microbicide acceptability among female sex workers in Beijing, China: results from a pilot study.

Authors:  Lin Han; Fan Lv; Peng Xu; Guolei Zhang; Naomi S Juniper; Zhenglai Wu
Journal:  J Womens Health (Larchmt)       Date:  2009-09       Impact factor: 2.681

4.  India-US collaboration to prevent adolescent HIV infection: the feasibility of a family-based HIV-prevention intervention for rural Indian youth.

Authors:  Asha Banu Soletti; Vincent Guilamo-Ramos; Denise Burnette; Shilpi Sharma; Alida Bouris
Journal:  J Int AIDS Soc       Date:  2009-11-19       Impact factor: 5.396

Review 5.  Moving beyond safe sex to women-controlled safe sex: a concept analysis.

Authors:  Kamila A Alexander; Christopher L Coleman; Janet A Deatrick; Loretta S Jemmott
Journal:  J Adv Nurs       Date:  2011-11-23       Impact factor: 3.187

6.  "Tell Juliana": acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study.

Authors:  Alex Carballo-Diéguez; Rebecca Giguere; Curtis Dolezal; Beatrice A Chen; Jessica Kahn; Greg Zimet; Marina Mabragaña; Cheng-Shiun Leu; Ian McGowan
Journal:  AIDS Behav       Date:  2012-10

7.  Using a 2-stage strategy with respondent-driven sampling to recruit a hard-to-reach population for a placebo microbicide gel clinical trial in Nellore, Andhra Pradesh (India).

Authors:  Waimar Tun; Lauren L Katzen; Sharon A Abbott; Aylur K Srikrishnan; Christine A Kelly; Avina Sarna; Barbara A Friedland; Suniti Solomon; Barbara S Mensch
Journal:  AIDS Behav       Date:  2015-02

8.  Preferred characteristics of vaginal microbicides in women with bacterial vaginosis.

Authors:  Robert L Cook; Julie S Downs; Jeanne Marrazzo; Galen E Switzer; Ozlem Tanriover; Harold Wiesenfeld; Pamela J Murray; Sharon L Hillier
Journal:  J Womens Health (Larchmt)       Date:  2009-08       Impact factor: 2.681

9.  Perceptibility and the "Choice Experience": User Sensory Perceptions and Experiences Inform Vaginal Prevention Product Design.

Authors:  Kate Morrow Guthrie; Shira Dunsiger; Sara E Vargas; Joseph L Fava; Julia G Shaw; Rochelle K Rosen; Patrick F Kiser; E Milu Kojic; David R Friend; David F Katz
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-29       Impact factor: 2.205

10.  Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.

Authors:  Andrew Vallely; Lisa Fitzgerald; Voletta Fiya; Herick Aeno; Angela Kelly; Joyce Sauk; Martha Kupul; James Neo; John Millan; Peter Siba; John M Kaldor
Journal:  BMC Res Notes       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.